國立虎尾科技大學 |

Integrated Omics Approaches to Infectious Diseases

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Integrated Omics Approaches to Infectious Diseases/ edited by Saif Hameed, Zeeshan Fatima.
other author:	Hameed, Saif.
Description:	XIX, 542 p. 78 illus., 69 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Medicine. -
Online resource:	https://doi.org/10.1007/978-981-16-0691-5
ISBN:	9789811606915

Integrated Omics Approaches to Infectious Diseases
Integrated Omics Approaches to Infectious Diseases[electronic resource] /edited by Saif Hameed, Zeeshan Fatima. - 1st ed. 2021. - XIX, 542 p. 78 illus., 69 illus. in color.online resource.

Chapter 1. Geno-Informatics for Prediction of Virulence and Drug Resistance in Bacterial Pathogens -- Chapter 2. Next Generation Sequencing: Challenges and Opportunities in Tuberculosis Research -- Chapter 3. Deciphering the role of epigenetic reprogramming in host-pathogen interactions -- Chapter 4. Genomic evidence provides the understanding of SARS-CoV-2 composition, divergence and diagnosis -- Chapter 5. Importance of Next Generation Sequencing in Viral Diagnostics -- Chapter 6. Bioinformatics application in CoVID19 -- Chapter 7. Emerging Transcriptomics approaches to decipher Mycobacterial complexities -- Chapter 8. Microarrays: A road map to uncover host pathogen interactions -- Chapter 9. Transcriptional Approach in the Identification of Drug Targets in Candida spp -- Chapter 10. Non-Coding RNA profiling: Potential Application in Infectious Diseases -- Chapter 11. RNA-seq analysis strategies to understand viral pathogenesis -- Chapter 12. Various Transcriptomic approaches & their applications to study small non-coding RNAs in Dengue and other viruses -- Chapter 13. Transcriptomic Approaches in Understanding Sars-COV-2 Infection -- Chapter 14. miRNA target prediction: Overview and applications -- Chapter 15. A Glimpse into Peptidomic Approach -- Chapter 16. Molecular mechanism of action of antimicrobial agents against clinically important human pathogens: A proteomic approach -- Chapter 17. Exploration of the mycobacterial proteome in the pathogenesis of TB: A perspective -- Chapter 18. Pathogenesis of Staphylococcus aureus and proteomic strategies for the identification of drug targets -- Chapter 19. Proteomics in the study of Host-Pathogen interactions -- Chapter 20. Significance of post-translational modifications in Apicomplexan parasites -- Chapter 21. An introduction to computational pipelines for analyzing untargeted metabolomics data for Leishmaniasis -- Chapter 22. Metabolomics: PromisingTool to Study Disease Biomarkers and Host-Pathogen Interactions -- Chapter 23. Lipidomics to study the role of lipid droplets in host-pathogen interactions -- Chapter 24. Lipid structure, function and lipidomic applications -- Chapter 25. Nanoparticles as Therapeutic Nanocargos affecting Epigenome of Microbial Biofilms -- Chapter 26. Malaria in the era of OMICS: Challenges and Way forward -- Chapter 27. Omics Approaches for Infectious Diseases -- Chapter 28. Pathogen-Omics: challenges and prospects in research and clinical settings.

This book examines applications of multi-omics approaches for understanding disease etiology, pathogenesis, host-pathogen interactions. It also analyzes the genetics, immunological and metabolic mechanisms underlying the infections. The book also explores genomics, transcriptomics, translational-omics, and metabolomics approaches to understand the pathogenesis and identify potential drug targets. It reviews the role of epigenetic reprogramming in shaping the host-pathogen interactions and presents bioinformatics application in the identification of drug targets. Further, it examines the potential applications of RNA sequencing and non-coding RNA profiling to identify the pathogenesis. Lastly, it offers the current challenges, technological advances, and prospects of using multi-omics technologies in infectious biology.

ISBN: 9789811606915

Standard No.: 10.1007/978-981-16-0691-5doiSubjects--Topical Terms:

644133
Medicine.

LC Class. No.: R-RZ

Dewey Class. No.: 610

Integrated Omics Approaches to Infectious Diseases
LDR:04670nam a22003975i 4500 001 1049534
003 DE-He213
005 20210718210017.0
007 cr nn 008mamaa
008 220103s2021 si | s |||| 0|eng d
020 $a 9789811606915 $9 978-981-16-0691-5
024 7 $a 10.1007/978-981-16-0691-5 $2 doi
035 $a 978-981-16-0691-5
050 4 $a R-RZ
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MBGR $2 thema
082 0 4 $a 610 $2 23
245 1 0 $a Integrated Omics Approaches to Infectious Diseases $h [electronic resource] / $c edited by Saif Hameed, Zeeshan Fatima.
250 $a 1st ed. 2021.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a XIX, 542 p. 78 illus., 69 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. Geno-Informatics for Prediction of Virulence and Drug Resistance in Bacterial Pathogens -- Chapter 2. Next Generation Sequencing: Challenges and Opportunities in Tuberculosis Research -- Chapter 3. Deciphering the role of epigenetic reprogramming in host-pathogen interactions -- Chapter 4. Genomic evidence provides the understanding of SARS-CoV-2 composition, divergence and diagnosis -- Chapter 5. Importance of Next Generation Sequencing in Viral Diagnostics -- Chapter 6. Bioinformatics application in CoVID19 -- Chapter 7. Emerging Transcriptomics approaches to decipher Mycobacterial complexities -- Chapter 8. Microarrays: A road map to uncover host pathogen interactions -- Chapter 9. Transcriptional Approach in the Identification of Drug Targets in Candida spp -- Chapter 10. Non-Coding RNA profiling: Potential Application in Infectious Diseases -- Chapter 11. RNA-seq analysis strategies to understand viral pathogenesis -- Chapter 12. Various Transcriptomic approaches & their applications to study small non-coding RNAs in Dengue and other viruses -- Chapter 13. Transcriptomic Approaches in Understanding Sars-COV-2 Infection -- Chapter 14. miRNA target prediction: Overview and applications -- Chapter 15. A Glimpse into Peptidomic Approach -- Chapter 16. Molecular mechanism of action of antimicrobial agents against clinically important human pathogens: A proteomic approach -- Chapter 17. Exploration of the mycobacterial proteome in the pathogenesis of TB: A perspective -- Chapter 18. Pathogenesis of Staphylococcus aureus and proteomic strategies for the identification of drug targets -- Chapter 19. Proteomics in the study of Host-Pathogen interactions -- Chapter 20. Significance of post-translational modifications in Apicomplexan parasites -- Chapter 21. An introduction to computational pipelines for analyzing untargeted metabolomics data for Leishmaniasis -- Chapter 22. Metabolomics: PromisingTool to Study Disease Biomarkers and Host-Pathogen Interactions -- Chapter 23. Lipidomics to study the role of lipid droplets in host-pathogen interactions -- Chapter 24. Lipid structure, function and lipidomic applications -- Chapter 25. Nanoparticles as Therapeutic Nanocargos affecting Epigenome of Microbial Biofilms -- Chapter 26. Malaria in the era of OMICS: Challenges and Way forward -- Chapter 27. Omics Approaches for Infectious Diseases -- Chapter 28. Pathogen-Omics: challenges and prospects in research and clinical settings.
520 $a This book examines applications of multi-omics approaches for understanding disease etiology, pathogenesis, host-pathogen interactions. It also analyzes the genetics, immunological and metabolic mechanisms underlying the infections. The book also explores genomics, transcriptomics, translational-omics, and metabolomics approaches to understand the pathogenesis and identify potential drug targets. It reviews the role of epigenetic reprogramming in shaping the host-pathogen interactions and presents bioinformatics application in the identification of drug targets. Further, it examines the potential applications of RNA sequencing and non-coding RNA profiling to identify the pathogenesis. Lastly, it offers the current challenges, technological advances, and prospects of using multi-omics technologies in infectious biology.
650 0 $a Medicine. $3 644133
650 0 $a Parasitology. $3 669054
650 0 $a Medical microbiology. $3 583124
650 0 $a Virology. $3 644995
650 1 4 $a Biomedicine, general. $3 1253757
650 2 4 $a Medical Microbiology. $3 668401
700 1 $a Hameed, Saif. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1301430
700 1 $a Fatima, Zeeshan. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1301431
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811606908
776 0 8 $i Printed edition: $z 9789811606922
776 0 8 $i Printed edition: $z 9789811606939
856 4 0 $u https://doi.org/10.1007/978-981-16-0691-5
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)